Author: Temgoua, Mazou Ngou; Kuaté, Liliane Mfeukeu; Ngatchou, William; Sibetcheu, Aurelie; Toupendi, Zouliatou Nzina; Belobo, Grace; Ossa, Alice; Kingue, Samuel
Title: Thromboembolic risks in patients with COVID-19: major concern to consider in our management Cord-id: ux5wjonx Document date: 2020_4_27
ID: ux5wjonx
Snippet: COVID-19 pandemic is an emergent cardiovascular risk factor and a major cause of mortality worldwide. Thromboembolism is highly suspected as a leading cause of death in these patients through vascular inflammation caused by SARS COV2. Until now there is no real treatment of COVID-19 and many proposed drugs are under clinical trials. Considering the high incidence of thromboembolic events in critically ill patients with COVID-19, prevention of this disorder should be essential in order to reduce
Document: COVID-19 pandemic is an emergent cardiovascular risk factor and a major cause of mortality worldwide. Thromboembolism is highly suspected as a leading cause of death in these patients through vascular inflammation caused by SARS COV2. Until now there is no real treatment of COVID-19 and many proposed drugs are under clinical trials. Considering the high incidence of thromboembolic events in critically ill patients with COVID-19, prevention of this disorder should be essential in order to reduce mortality in these patients.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date